BACKGROUND: Complicated tibial fractures with severe soft tissue trauma are challenging to treat. Frequently associated acute compartment syndrome can result in scarring of muscles with impaired function. Several studies have shown a relationship between angiogenesis and more effective muscle regeneration. Vascular endothelial growth factor (VEGF) is associated with angiogenesis but it is not clear whether it would restore muscle force, reduce scarring, and aid in muscle regeneration after acute musculoskeletal trauma. QUESTIONS/PURPOSES: Therefore, we asked whether local application of VEGF (1) restores muscle force, (2) reduces scar tissue formation, and (3) regenerates muscle tissue. METHODS: We generated acute soft tissue trauma with increased compartment pressure in 22 rabbits and shortened the limbs to simulate fracture débridement. In the test group (n = 11), a VEGF-coated collagen matrix was applied locally around the osteotomy site. After 10 days of limb shortening, gradual distraction of 0.5 mm per 12 hours was performed to restore the original length. Muscle force was measured before trauma and on every fifth day after trauma. Forty days after shortening we euthanized the animals and histologically determined the percentage of connective and muscle tissue. RESULTS: Recovery of preinjury muscle strength was greater in the VEGF group (2.4 N; 73%) when compared with the control (1.8 N; 53%) with less connective and more muscle tissue in the VEGF group. The recovery of force was related to the percentage of connective tissue versus muscle fibers. CONCLUSIONS: Local application of VEGF may improve restoration of muscle force by reducing connective tissue and increasing the relative amount of muscle fibers. CLINICAL RELEVANCE: VEGF may be useful to improve skeletal muscle repair by modulating muscle tissue regeneration and fibrosis reduction after acute trauma.
BACKGROUND: Complicated tibial fractures with severe soft tissue trauma are challenging to treat. Frequently associated acute compartment syndrome can result in scarring of muscles with impaired function. Several studies have shown a relationship between angiogenesis and more effective muscle regeneration. Vascular endothelial growth factor (VEGF) is associated with angiogenesis but it is not clear whether it would restore muscle force, reduce scarring, and aid in muscle regeneration after acute musculoskeletal trauma. QUESTIONS/PURPOSES: Therefore, we asked whether local application of VEGF (1) restores muscle force, (2) reduces scar tissue formation, and (3) regenerates muscle tissue. METHODS: We generated acute soft tissue trauma with increased compartment pressure in 22 rabbits and shortened the limbs to simulate fracture débridement. In the test group (n = 11), a VEGF-coated collagen matrix was applied locally around the osteotomy site. After 10 days of limb shortening, gradual distraction of 0.5 mm per 12 hours was performed to restore the original length. Muscle force was measured before trauma and on every fifth day after trauma. Forty days after shortening we euthanized the animals and histologically determined the percentage of connective and muscle tissue. RESULTS: Recovery of preinjury muscle strength was greater in the VEGF group (2.4 N; 73%) when compared with the control (1.8 N; 53%) with less connective and more muscle tissue in the VEGF group. The recovery of force was related to the percentage of connective tissue versus muscle fibers. CONCLUSIONS: Local application of VEGF may improve restoration of muscle force by reducing connective tissue and increasing the relative amount of muscle fibers. CLINICAL RELEVANCE: VEGF may be useful to improve skeletal muscle repair by modulating muscle tissue regeneration and fibrosis reduction after acute trauma.
Authors: Cristina Borselli; Hannah Storrie; Frank Benesch-Lee; Dmitry Shvartsman; Christine Cezar; Jeff W Lichtman; Herman H Vandenburgh; David J Mooney Journal: Proc Natl Acad Sci U S A Date: 2009-12-04 Impact factor: 11.205
Authors: Bridget M Deasy; Joseph M Feduska; Thomas R Payne; Yong Li; Fabrisia Ambrosio; Johnny Huard Journal: Mol Ther Date: 2009-07-14 Impact factor: 11.454
Authors: Katharina Schmidt-Bleek; Hanna Schell; Paula Kolar; Michael Pfaff; Carsten Perka; Frank Buttgereit; Georg Duda; Jasmin Lienau Journal: J Orthop Res Date: 2009-09 Impact factor: 3.494
Authors: Rainer H Meffert; Sönke P Frey; Hendrik Jansen; Sabine Ochman; Michael J Raschke; Martin Langer Journal: J Orthop Res Date: 2008-11 Impact factor: 3.494
Authors: Chester Bittencourt Sacramento; Flavia Helena da Silva; Nance Beyer Nardi; Eduardo Gallatti Yasumura; José Carlos Costa Baptista-Silva; Abram Beutel; Ruy Ribeiro de Campos; Jane Zveiter de Moraes; Hamilton Silva Junior; Vivian Yochiko Samoto; Radovan Borojevic; Sang Won Han Journal: J Gene Med Date: 2010-03 Impact factor: 4.565
Authors: Fan Yang; Seung-Woo Cho; Sun Mi Son; Said R Bogatyrev; Deepika Singh; Jordan J Green; Ying Mei; Sohyun Park; Suk Ho Bhang; Byung-Soo Kim; Robert Langer; Daniel G Anderson Journal: Proc Natl Acad Sci U S A Date: 2009-10-05 Impact factor: 11.205
Authors: Juan Liu; Dominik Saul; Kai Oliver Böker; Jennifer Ernst; Wolfgang Lehman; Arndt F Schilling Journal: Biomed Res Int Date: 2018-04-16 Impact factor: 3.411
Authors: S Moimas; F Novati; G Ronchi; S Zacchigna; F Fregnan; L Zentilin; G Papa; M Giacca; S Geuna; I Perroteau; Z M Arnež; S Raimondo Journal: Gene Ther Date: 2013-05-30 Impact factor: 5.250